These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18045152)

  • 1. Macrophage infiltration, lectin-like oxidized-LDL receptor-1, and monocyte chemoattractant protein-1 are reduced by chronic HMG-CoA reductase inhibition.
    Tsuchiya A; Nagotani S; Hayashi T; Deguchi K; Sehara Y; Yamashita T; Zhang H; Lukic V; Kamiya T; Abe K
    Curr Neurovasc Res; 2007 Nov; 4(4):268-73. PubMed ID: 18045152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats.
    Hamakawa Y; Omori N; Ouchida M; Nagase M; Sato K; Nagano I; Shoji M; Fujita T; Abe K
    Neurol Res; 2004 Oct; 26(7):767-73. PubMed ID: 15494120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
    Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
    Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation.
    Bea F; Blessing E; Shelley MI; Shultz JM; Rosenfeld ME
    Atherosclerosis; 2003 Apr; 167(2):187-94. PubMed ID: 12818400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect.
    Gómez-Garre D; Muñoz-Pacheco P; González-Rubio ML; Aragoncillo P; Granados R; Fernández-Cruz A
    Br J Pharmacol; 2009 Apr; 156(8):1218-27. PubMed ID: 19222481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
    Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
    Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
    Alfon J; Guasch JF; Berrozpe M; Badimon L
    Atherosclerosis; 1999 Aug; 145(2):325-31. PubMed ID: 10488960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiatherogenic effect of simvastatin is not due to decrease of LDL cholesterol in ovariectomized golden Syrian hamster.
    Pitha J; Bobková D; Kovář J; Havlíčková J; Poledne R
    Physiol Res; 2010; 59(3):401-406. PubMed ID: 19681658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.
    Takayama N; Kai H; Kudo H; Yasuoka S; Mori T; Anegawa T; Koga M; Kajimoto H; Hirooka Y; Imaizumi T
    Hypertens Res; 2011 Mar; 34(3):341-7. PubMed ID: 21124329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simvastatin on NF-kappaB-DNA binding activity and monocyte chemoattractant protein-1 expression in a rabbit model of atherosclerosis.
    Yang X; Wang L; Zeng H; Dubey L; Zhou N; Pu J
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):194-8. PubMed ID: 16850745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing lipid lowering and plasma cholesteryl ester transfer protein activity of simvastatin following administration to rabbits fed a high fat/cholesterol diet.
    Risovic V; Man D; Sivak O; Lee SD; Wasan KM
    Drug Dev Ind Pharm; 2006 Jun; 32(5):609-15. PubMed ID: 16720415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein.
    Sakai M; Kobori S; Matsumura T; Biwa T; Sato Y; Takemura T; Hakamata H; Horiuchi S; Shichiri M
    Atherosclerosis; 1997 Aug; 133(1):51-9. PubMed ID: 9258407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats.
    Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
    Stroke; 2008 Apr; 39(4):1276-85. PubMed ID: 18309148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease.
    Vieira JM; Rodrigues LT; Mantovani E; Dellê H; Mattar AL; Malheiros DM; Noronha IL; Fujihara CK; Zatz R
    Nephron Physiol; 2005; 101(4):p82-91. PubMed ID: 16113589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.